Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers with corporate access will find a wealth of contextualized life science insight ready to be viewed in the FENIX Marketplace.
Welcome to FENIX Syndicated Services. If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact us.
$599
Posted in: Basal Insulin, Bolus Insulin, Glucagon, Glucose Monitoring, Other Aug 12 | 2021New Non-invasive CGM Startup Raises $11.7M in Series B; Zealand, Mannkind, and Metacrine Q2 '21 Earnings Updates; Integrity Applications Reverse Stock SplitPurchase Blast
$599
Posted in: Glucose Monitoring, Other Aug 10 | 2021Lifescan and Fitbit Diabetes Collaboration; Sigilon Q2 '21 Earnings UpdatePurchase Blast$599
Posted in: Basal Insulin, Bolus Insulin, Other Aug 09 | 2021Viatris and Senseonics Q2 '21 Earnings Updates; Forxiga CKD EU Approval; GoodRx and BI Patient Access Initiative; Diamyd EU Patent Granted; New Glooko CTOPurchase Blast
$599
Posted in: Glucagon, Insulin Delivery, Other Aug 06 | 2021Xeris, Amarin, Regeneron, and BD Q2 '21 Earnings UpdatesPurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery, Other Aug 05 | 2021Omnipod 5 Delayed; Insulet, Provention Bio, and Bayer Q2 '21 Earnings UpdatesPurchase Blast$599
Posted in: Glucose Monitoring, Insulin Delivery, Other Aug 04 | 2021Tandem, Ionis, Esperion, and Amgen Q2 '21 Earnings Updates; Dario Gains National Digital Behavioral Health ContractPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, Other Aug 04 | 2021Wegovy Launch Impresses; Guidance Raised; Novo Q2 '21 Earnings UpdatePurchase Blast
$599
Posted in: Glucose Monitoring, Other Aug 02 | 2021Libre 2 iOS App Cleared in US; Novartis Pelacarsen CVOT Reaches 50% EnrollmentPurchase Blast
$599
Posted in: DPP-IVi, Dual/triple agonist, Other, SGLT2i Jul 30 | 2021Lexicon, Merck, and Intercept Q2 '21 Earnings UpdatePurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin Jul 29 | 2021Semglee (Bs-glargine) Receives US Interchangeability; Sanofi Q2 '21 Earnings UpdatePurchase Blast
$599
Posted in: Glucose Monitoring, Other Jul 28 | 2021Lifescan and Noom Expand Partnership; Supersapiens Adds Zisser and Ketchell to Leadership Team; Teladoc, Pfizer, and Teva Q2 ’21 Earnings UpdatePurchase Blast
$599
Posted in: Other Jul 27 | 2021AZ and Regeneron Collaborate on Obesity Treatment DevelopmentPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA Jul 23 | 2021Bydureon BCise US Pediatric Approval; Biocon FY Q1 ’22 (CY Q2 ’21) Earnings Update; Afrezza Pediatric Ph3 Trial ObservedPurchase Blast$599
Posted in: Glucose Monitoring, Insulin Delivery, Other Jul 22 | 2021Abbott, Roche, and Adocia Q2 '21 Earnings UpdatesPurchase Blast